Formula: | C18H16FN3O |
Molecular Weight: | 309.34 |
Rotatable Bond Donors: | 0 |
clogP: | 3.99 |
Topological Polar Surface Area: | 61.54 |
Lipinski's RO5: | MW: 309.34 HBA: 4 HBD: 2 RB: 0 LogP: 3.99 |
Rule of Three: | MW: 309.34 HBA: 4 HBD: 2 RB: 0 LogP: 3.99 |
|
DB |
---|
ZINC ID | Similarity | Structure | SDF |
---|
ZINC ID | Similarity | Structure | SDF | |
---|---|---|---|---|
ZINC12504479 | 1.0 | ZINC12504479 RDKit 3D 23 26 0 0 0 0 0 0 0 0999 V2000 4.9200 1.1989 -0.9181 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2853 -0.1343 -0.5863 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5846 -1.0909 -1.7197 C 0 0 0 0 0 0 0 0 0 0 0 0 4.9267 -0.6563 0.6807 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8147 0.0105 -0.4030 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0970 1.1140 -0.5006 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7949 0.7430 -0.2478 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.3839 1.5058 -0.2180 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.2738 2.9318 -0.4919 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3883 3.6679 -0.4664 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6075 3.1130 -0.1922 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8290 1.7721 0.0822 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.9470 1.3287 0.3218 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.6187 0.8874 0.0700 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6876 -0.5036 0.3317 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8706 -1.2035 0.6270 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8621 -2.5755 0.8743 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.0127 -3.2030 1.1519 F 0 0 0 0 0 0 0 0 0 0 0 0 -1.6809 -3.3056 0.8382 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4893 -2.6527 0.5502 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.4963 -1.2707 0.3008 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7158 -0.6205 0.0104 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0089 -1.0563 -0.0950 N 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 2 4 1 0 2 5 1 0 5 6 2 0 6 7 1 0 7 8 2 0 8 9 1 0 9 10 2 0 10 11 1 0 11 12 1 0 12 13 2 0 12 14 1 0 14 15 2 0 15 16 1 0 16 17 2 0 17 18 1 0 17 19 1 0 19 20 2 0 20 21 1 0 21 22 2 0 22 23 1 0 23 5 1 0 22 7 1 0 14 8 1 0 21 15 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
Single dose inhibition of SARS-CoV-2 cytopathic effect in VeroE6 | primary assay | Organism Severe acute respiratory syndrome-related coronavirus | inactive |
Single dose inhibition of SARS-CoV-2 3CL-Pro | primary assay | Replicase polyprotein 1ab | inactive |